Treace Medical Concepts, Inc. provided revenue guidance for the full year 2022. The company expects revenue for the full year 2022 to range from $125 million to $130 million, which represents approximately 32% to 38% growth over the company's 2021 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 USD | +1.37% | -1.82% | -53.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.41% | 368M | |
+75.69% | 12.57B | |
+11.91% | 6.96B | |
-29.01% | 6.92B | |
+9.77% | 5.24B | |
-20.60% | 4.6B | |
+13.02% | 4.02B | |
-21.88% | 3.77B | |
-29.14% | 2.67B | |
+27.73% | 2.05B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2022